High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma

Table 1

Clinicopathologic characteristics of 169 PDAC patients.

Patients characteristics	Number of cases (%)
Age (years)
≤60	76 (45.0)
>60	93 (55.0)
Gender
Male	96 (56.8)
Female	73 (43.2)
Clinical stage
I or II	95 (56.2)
III or IV	74 (43.8)
T classification
T1 or T2	38 (22.5)
T3 or T4	131 (77.5)
N classification
N0	98 (58.0)
N1-2	71 (42.0)
Metastasis
No	163 (96.4)
Yes	6 (3.6)
Pathologic differentiation
High (middle or high)	115 (68.0)
Low (No or low)	54 (32.0)
Vascular invasion
No	119 (70.4)
Yes	50 (29.6)
Neural invasion
No	87 (51.5)
Yes	82 (48.5)
Vital states（at follow-up）
Alive	70 (41.4)
Dead	99 (58.6)
Expression of COL17A1
Low expression	63 (37.3)
High expression	106 (62.7)